<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04611737</url>
  </required_header>
  <id_info>
    <org_study_id>KMUHIRB-SV(I)-20200019</org_study_id>
    <nct_id>NCT04611737</nct_id>
  </id_info>
  <brief_title>Self-Determination Theory and Motivational Interviewing</brief_title>
  <official_title>Developing and Testing of Integrating Self-Determination Theory and Motivational Interviewing Based Diabetic Self-management Program Among Schizophrenic Patients With Diabetes</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Kaohsiung Medical University Chung-Ho Memorial Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Kaohsiung Medical University Chung-Ho Memorial Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Self-Determination Theory and motivational interviewing would be integrated to enhance the&#xD;
      efficacy of diabetic self-management for patients with schizophrenia and Type 2 Diabetes.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Participants would be randomly allocated into either the intervention group or the usual care&#xD;
      group from baseline to 3 months follow-up. The intervention is based on integrated&#xD;
      self-determination theory and motivational interviewing.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">November 3, 2020</start_date>
  <completion_date type="Anticipated">January 2023</completion_date>
  <primary_completion_date type="Anticipated">October 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>HbA1C</measure>
    <time_frame>on interviewing day1, and 3 months</time_frame>
    <description>Blood sugar level during the 3 months</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Body weight</measure>
    <time_frame>on interviewing day1, and 3 months</time_frame>
    <description>weight (in kilograms)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>height</measure>
    <time_frame>on interviewing day1, and 3 months</time_frame>
    <description>height (in meters), eight and height will be combined to report BMI in kg/m^2</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Brief Psychiatric Rating Scale</measure>
    <time_frame>on interviewing day1, and 3 months</time_frame>
    <description>The Brief Psychiatric Rating Scale with 18 items is use to measure psychiatric symptoms. Each symptom is rated 1-7 with higher scores indicating severer symptoms.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Treatment Self-Regulation Questionnaire-Diabetes</measure>
    <time_frame>on interviewing day1, and 3 months</time_frame>
    <description>The treatment Self-Regulation Questionnaire-Diabetes a 19-item scale used to examine the self-regulation behaviors for diabetes of participants. Each item is ranged from 1 to 7 and higher scores showing more motivations in self-regulation diabetes.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Perceived Diabetes Self-Management Scale</measure>
    <time_frame>on interviewing day1, and 3 months</time_frame>
    <description>The Perceived Diabetes Self-Management Scale is an 8-item scale with 4 of the items (1, 2, 6, &amp; 7) being reverse-scored. Each item is ranged from 1 to 5 and higher scores showing more confidence in self-managing diabetes.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Depression Anxiety Stress Scales</measure>
    <time_frame>on interviewing day1, and 3 months</time_frame>
    <description>The Depression Anxiety Stress Scales is a self-report scale with 21 items designed to assess depression, stress and anxiety of participants. Scores for each symptom is ranged from 0 to 3 with higher scores indicating severer symptoms.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">50</enrollment>
  <condition>Schizophrenia</condition>
  <condition>Diabetes</condition>
  <arm_group>
    <arm_group_label>Experimental group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>The researcher interviews with participants for 3 times.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control group</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>The participants receive usual care.</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Interviewing</intervention_name>
    <description>Self-Determination Theory within motivational interviewing</description>
    <arm_group_label>Experimental group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  patients with schizophrenia and Type 2 Diabetes&#xD;
&#xD;
          -  between 20 years old to 80 years old&#xD;
&#xD;
          -  can communicate in Chinese langue&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  can not communicate well&#xD;
&#xD;
          -  have neurocognitive disorders&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Ching-Yun Yu, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Assistant professor, School of Nursing, Kaohsiung Medical University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Ching-Yun Yu, PhD</last_name>
    <phone>8863121101</phone>
    <phone_ext>2608</phone_ext>
    <email>cyyu@kmu.edu.tw</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Chien Yu Lai, PhD</last_name>
    <phone>88628227101</phone>
    <phone_ext>3141</phone_ext>
    <email>chienlai@ntunhs.edu.tw</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Kaohsiung Medical University Hospital</name>
      <address>
        <city>Kaohsiung</city>
        <zip>807</zip>
        <country>Taiwan</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ching Y Yu, PhD</last_name>
      <phone>88673121101</phone>
      <phone_ext>2608</phone_ext>
      <email>cyyu@kmu.edu.tw</email>
    </contact>
    <contact_backup>
      <last_name>Chien Yu Lai, PhD</last_name>
      <phone>88628227101</phone>
      <phone_ext>3114</phone_ext>
      <email>chienlai@ntunhs.edu.tw</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>Taiwan</country>
  </location_countries>
  <verification_date>October 2020</verification_date>
  <study_first_submitted>October 25, 2020</study_first_submitted>
  <study_first_submitted_qc>October 27, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">November 2, 2020</study_first_posted>
  <last_update_submitted>November 5, 2020</last_update_submitted>
  <last_update_submitted_qc>November 5, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">November 9, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Schizophrenia</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

